Special Issues
Table of Content

Innovations in Genitourinary Oncology: Integrating Tumor Immunology and Precision Medicine

Submission Deadline: 01 March 2026 (closed) View: 557 Submit to Journal

Guest Editor(s)

Prof. Dr. Leonardo Oliveira Reis

Email: reisleo.l@gmail.com

Affiliation: UroScience, School of Medical Sciences, University of Campinas, Campinas, 13083-887, Brazil.

Homepage:

Research Interests: genitourinary cancer, tumor immunology

图片1.png


Summary

The Special Issue aims to gather high-impact, interdisciplinary research at the forefront of genitourinary (GU) oncology and tumor immunology. Genitourinary cancers, including malignancies of the prostate, bladder, kidney, testis, and other components of the urinary and reproductive systems, pose a substantial global health burden. Despite significant advances in diagnostics and therapeutics, major challenges persist in early detection, treatment resistance, disease recurrence, and patient stratification.


This Special Issue will serve as a platform to showcase innovative translational and clinical research that integrates insights from oncology, immunology, molecular biology, bioinformatics, and biomedical engineering. It will emphasize the evolving understanding of tumor-immune interactions, novel immunotherapeutic approaches, biomarker discovery, and precision medicine strategies tailored to GU malignancies.


Keywords

·Tumor microenvironment and immune modulation in genitourinary cancers
·Checkpoint inhibitors, CAR-T cell therapy, and other immunotherapies
·Tumor antigen discovery and neoantigen prediction in GU tumors
·Molecular profiling and genomic alterations in GU cancers
·Biomarkers for response and resistance to immunotherapy
·Immuno-oncology clinical trials in bladder, prostate, and renal cancers
·Combination therapies integrating immunotherapy with chemotherapy, targeted therapy, or radiation
·Liquid biopsies, circulating tumor DNA, and non-invasive diagnostics
·Artificial intelligence and machine learning applications in immuno-oncology
·Comparative oncology and insights from animal models of GU cancer
·Health disparities, ethics, and personalized approaches in GU immuno-oncology

Published Papers


  • Open Access

    REVIEW

    Nanorobots and Exosomes: Driving the New Frontier for Bladder Tumors through Non-Coding RNAs

    Lorenzo Spirito, Cristina Quintavalle, Paola Coppola, Matteo Esposito, Francesco Esposito, Gabriella De Vita, Pierlorenzo Pallante
    Oncology Research, DOI:10.32604/or.2026.078045
    (This article belongs to the Special Issue: Innovations in Genitourinary Oncology: Integrating Tumor Immunology and Precision Medicine)
    Abstract Because of its limited treatment choices and high recurrence rates, bladder cancer (BCa) presents a significant clinical issue. As a result, current research is concentrated on creating novel approaches for early diagnosis and more specialized treatments. Nanorobots hold significant potential as precise medicine-delivery systems and as in situ diagnostic vectors within this dynamic environment. Personalized treatments are becoming increasingly feasible thanks to new insights into the molecular pathways driving tumor growth, revealed through studies on exosomes and non-coding RNAs (ncRNAs), however, their true potential lies in integrating these findings. This review analyzes the role of nanorobots,… More >

Share Link